Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05627687 · ClinicalTrials.gov registry record · Phase 1
Caring Relationships Expression Study
A Phase 1 study, sponsored by Arizona State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT05627687: Completed Phase 1 study, sponsored by Arizona State University.
NCT05627687 is a Phase 1 study that has completed, run by Arizona State University. The registered enrollment target is 38 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (37% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05627687, a Phase 1 study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study will examine a heart rate variability biofeedback (HRVB) intervention versus a music listening control (MLC) for 30 family caregivers (FCGs) of Alzheimer's disease (AD) (and related dementias: ADRD) patients to examine feasibility (acceptability/adherence, satisfaction) and direction of change in caregiver burden, stress, resilience, anxiety, self-compassion, and relationship quality over the course of 8-weeks.
Primary Outcome
10 items describing stress, response format 0-4, total score range 0-40, higher scores indicating worse stress
Interventions
- BEHAVIORAL Heart Rate Variability Biofeedback
- BEHAVIORAL Music Listening Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2021-12-13 |
| Est. Completion | 2023-07-01 |
| Phase | Phase 1 |
What the finished NCT05627687 record still lists
NCT05627687 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (37% lower).
The record links to 0 conditions, and to 2 interventions - of which Heart Rate Variability Biofeedback is the first listed.
NCT05627687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05627687 about?
NCT05627687 is a clinical study titled "Caring Relationships Expression Study". This study will examine a heart rate variability biofeedback (HRVB) intervention versus a music listening control (MLC) for 30 family caregivers (FCGs) of Alzheimer's disease (AD) (and related dementias: ADRD) patients to examine feasibility (acceptability/adherence, satisfaction) and direction of c...
What is the current status of trial NCT05627687?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2021-12-13. Estimated completion is 2023-07-01.
What interventions are being tested in trial NCT05627687?
The interventions under investigation include: Heart Rate Variability Biofeedback (BEHAVIORAL), Music Listening Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05627687?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05627687's enrollment target sits among peer trials
38 1197th of 2000 higher than 797 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI